Completed

Comparison of Behavioral and Standard Treatment Outcomes in Buprenorphine Detox

What is being tested

Data Collection

Who is being recruted

Narcotic-Related Disorders+2

+ Mental Disorders

+ Opioid-Related Disorders

Over 18 Years

See all eligibility criteria

How is the trial designed

Treatment Study

Phase 2

Interventional

Study Start: August 1994

See protocol details

Summary

Principal SponsorNational Institute on Drug Abuse (NIDA)

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: August 1, 1994

Actual date on which the first participant was enrolled.

This study focuses on comparing two different types of treatment for individuals undergoing buprenorphine detox: behavioral treatment and standard treatment. The goal is to determine which approach is more effective in helping people overcome substance use disorder. The study is particularly important as it aims to find the best way to support those going through buprenorphine detox, potentially improving care and treatment outcomes for this specific group of individuals. Participants in this study will receive either behavioral treatment or standard treatment while undergoing buprenorphine detox. The study measures several outcomes to evaluate the effectiveness of each treatment type, including overall drug use, treatment outcome, participant retention, and the number of weeks participants remain abstinent. Additionally, the study will look at the number of weeks participants maintain continuous abstinence.

Official TitleBuprenorphine Detox With Two Types of Treatment. BBD I

NCT00000228

Principal SponsorNational Institute on Drug Abuse (NIDA)

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Narcotic-Related DisordersMental DisordersOpioid-Related DisordersSubstance-Related DisordersChemically-Induced Disorders

Criteria

Please contact site for information.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Treatment Research Center

Burlington, United StatesOpen Treatment Research Center in Google Maps

CompletedOne Study Center